10
Loading video...

By Alexis Kayser
Healthcare Editor
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Watch the full webinar, "What Does It Take to Lead in the Value-Based Care Economy? A Conversation with Optum Health CEO Krista Nelson," above, or access an on-demand replay here.
Before the term "value-based care" entered the U.S. health care lexicon, leaders were already being asked to rethink a system that rewarded volume over outcomes. Decades later, the pace of that transition can still make it difficult to tell where experimentation ends and a durable new payment system begins.
But the signals coming from the Centers for Medicare & Medicaid Services are getting harder to dismiss. The agency is pushing more Medicare beneficiaries into accountable care arrangements and asking providers to take greater responsibility for both the quality and cost of care. As Krista Nelson, CEO of Optum Health, confirmed during a recent Newsweek webinar, that direction is increasingly shaping how health care organizations need to operate.
Read More on Health Care Vertical
"I think CMS' intention and their goal is that every Medicare eligible [person] has access to value-based care," Nelson said, speaking to an audience of health care leaders during a virtual fireside chat on August 17.
"And it's not just through Medicare Advantage that you can get access to value-based care," Nelson added, describing CMS’s vision for a future in which "that kind of model, that kind of investment is offered for everybody in traditional Medicare as well."

...
CMS has explicitly described its value-based programs as part of a broader effort to shift Medicare from paying providers based on the quantity of care they deliver toward rewarding the quality of that care. Increasingly, that philosophy is showing up not only in experimental payment models but in the financial architecture surrounding Medicare.
Beginning in 2026, for example, physicians who qualify through participation in Advanced Alternative Payment Models receive a higher annual Medicare Physician Fee Schedule update than clinicians who do not: 0.75 percent versus 0.25 percent. The CMS Innovation Center's current strategy goes further, calling for future models to expand prospective payments and advanced shared savings while moving Medicare and Medicaid beneficiaries toward accountable care arrangements in which providers assume global downside financial risk.
CMS reinforced that direction again last month. Its proposed 2027 Medicare Physician Fee Schedule would make changes intended to expand participation in accountable care organizations and move clinicians away from traditional MIPS reporting toward what the agency describes as more meaningful value-based pathways. Meanwhile, more than 700,000 health care providers and organizations are participating in Medicare accountable care initiatives in 2026.
As the details of individual programs continue to change, the broader question for health care leaders is what those payment signals add up to, and how organizations should respond while the value-based model is still a work in progress.
It's the question that health care stakeholders hoped to unpack when Nelson, CEO of one of the largest physician organizations in the United States, took the virtual stage to discuss leadership in the value-based care economy.
Optum is the health services business of UnitedHealth Group, the largest U.S. health care company by revenue and No. 3 overall on the 2026 Fortune 500 (behind Amazon and Walmart, and ahead of Apple and Alphabet). With a presence in all 50 states and the District of Columbia, Optum supports more than 120 million customers, according to UnitedHealth Group's most recent earnings report.

...
Through Optum Health, the company delivers and manages care across primary, specialty, surgical, behavioral and home-based settings, giving Nelson a particularly expansive view of the industry's shift toward value.
That perspective has taught her that value-based care does not look the same everywhere.
Nelson described meaningful variation in performance across markets, reflecting differences in patient populations, payer relationships, physician practices and the maturity of local value-based models. For organizations operating at scale, it's an ongoing challenge to reproduce what works without assuming that every market will follow the same path.
Optum Health's Houston market offers one example of what successful value-based care can look like. This region cares for about 1 million patients across a comprehensive set of service lines, but is "really anchored in primary care," according to Nelson.
"In Houston, we have about a 15 to 30 percent total cost of care reduction compared to alternative [providers] in Houston," she said. "At the same time, our net promoter score—or our patient satisfaction as measured by our patients—is 90. And in that market, we have one of the lowest provider attrition numbers."
"It is possible to actually do all of those things," Nelson continued. "It takes a lot of work. It takes investment and tools. It takes partnership with payers and providers to make that happen."
Those results speak to what Nelson described as the "quadruple aim" of value-based care: improving quality outcomes while lowering costs and creating a better experience for both patients and clinicians.
"The research is mounting that value-based care does deliver better quality, does deliver a lower cost while delivering a better experience," Nelson said.
There is evidence to support parts of that argument, although results have varied considerably by program and provider.
A 2018 study of the Medicare Shared Savings Program found that participation by physician-group ACOs was associated with Medicare spending reductions that grew with longer participation. By 2015, physician groups that had entered the program in 2012 had reduced spending by an estimated 4.9 percent relative to the study's comparison group. However, the researchers found much smaller savings among hospital-integrated ACOs, underscoring how organizational structure can affect results.
Another 2019 study of ACOs serving rural and underserved areas found that providing organizations with upfront investment to participate in accountable care was associated with lower Medicare spending. Researchers estimated a net reduction of $48.6 million after accounting for CMS' upfront payments and shared-savings bonuses.
And the benefits may extend beyond spending. An older study, published in NEJM in 2014, found that ACO contracts were associated with improvements in some measures of patient experience while performance on others remained unchanged.
More recent CMS results point in the same direction. In performance year 2024, Medicare Shared Savings Program ACOs saved Medicare $2.5 billion while earning $4.1 billion in shared savings payments. CMS also reported improvements in patient measures including blood pressure control, diabetes control and depression screening.
But translating those results into an industry-wide model remains a mighty challenge.

...
For CMS to achieve its broader ambitions for accountable care, payers and providers will have to overcome one of value-based care's longstanding problems—failure to scale.
"The challenge that we all have is, how do we scale these models faster?" Nelson said. "How do we think about taking that to CMS in a way that we could offer these models in traditional Medicare?"
She pointed to the Medicare Shared Savings Program, ACO REACH and the forthcoming Long-term Enhanced ACO Design, or LEAD, Model as evidence of CMS' interest in developing durable pathways for accountable care in traditional Medicare.
ACO REACH reduced gross spending and improved quality over its first four performance years, CMS said in July. The model ends this year, but some of its lessons will feed into LEAD, a 10-year model scheduled to launch in January 2027.
But scaling value-based care is not simply a question of government policy or provider participation, Nelson noted. It also requires payers and providers to agree on how risk is measured, how success is rewarded and how the investments required to change care delivery are financed.
That relationship has become particularly important as organizations contend with rising medical costs and a changing Medicare Advantage environment. A model built around reducing total cost of care becomes more difficult to sustain when the underlying care delivery costs are rising faster than organizations anticipated.
Organizations across the health care sector are feeling the pressure, according to Nelson.
"The industry has really been through a lot," she said, pointing to regulatory changes, rising medical cost trends and instances in which payers mispriced that trend—a group that includes UnitedHealth Group itself. In its Q2 2025 disclosures, the company said it expected MA medical cost trend to run at about 7.5 percent for 2025, versus a pricing assumption of just over five percent. UnitedHealthcare CEO Tim Noel subsequently acknowledged that its pricing and assumptions about patient health status had fallen “well-short” of the medical costs actually incurred.
That leaves health plans and providers confronting medical costs that are rising faster than the funding available to cover them, Nelson said, while regulators simultaneously push the industry to constrain total cost of care.
"We have regulators essentially asking all of us in the industry to make sure that we're helping to lower that total cost of care," Nelson said on August 17. "And so the growth rate isn't keeping up with the same rate of trend."
Those pressures add consequence to the industry's next value-based care moves—and complicate the idea that there is a single verdict on whether the model "works."

...
Indeed, some recent research has challenged more optimistic assessments of Medicare's accountable care programs. One 2026 JAMA Health Forum analysis argued that estimates of Medicare Shared Savings Program savings are sensitive to factors including participant selection and changes in diagnostic coding, and concluded that evidence of meaningful net savings to Medicare remains limited.
The variable results contribute to mixed messaging around value-based care programs, creating confusion around both CMS' chosen direction and its plausibility. Many industry executives champion these care models as a path toward better outcomes and a more sustainable health care system. Their confidence is reflected in the value-based care service market, forecasted to grow from $4.14 billion in 2025 to $6.57 billion in 2030, according to this year's global outlook from the Business Research Company. Still, providers have raised concerns about the financial risk, administrative complexity and upfront investment required to participate, while payers and health systems continue to debate how risk should be shared and performance should be measured.
The result is an industry that—as Nelson pointed out—is moving toward value-based care without a unanimous definition of success or a clear timeline to achieve it. Meanwhile, CMS continues to refine the mechanics of its programs, requiring organizations to adapt in real time.
One audience member at Newsweek's August 17 webinar alluded to that tension, asking Nelson, "Why do we continue to hear and read about orgs struggling to scale VBC? Even to the point where many say it is failing?"
For Nelson, the evidence does not suggest that value-based care has failed, but that the model has to keep evolving.
"This isn't about anything failing," Nelson said. "This is really about how we continue to modernize, to adapt to those changing forces, work with our partners to ensure that we can deliver the care we need to deliver for our patients."
Click here to access the full on-demand replay of Newsweek's August 17 webinar, "What Does It Take to Lead in the Value-Based Care Economy? A Conversation with Optum Health CEO Krista Nelson."
Click here to register for Newsweek's next interactive health care webinar on Thursday, September 3: "What Makes a Smart Hospital?" featuring executives from NYU Langone Health, Samsung Medical Center, Sheba Medical Center, ARC Innovation and Statista.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines